GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Interest Expense

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Interest Expense : ¥-15 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hubei Hongyuan Pharmaceutical Technology Co's interest expense for the three months ended in Mar. 2024 was ¥ -3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-15 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hubei Hongyuan Pharmaceutical Technology Co's Operating Income for the three months ended in Mar. 2024 was ¥ 35 Mil. Hubei Hongyuan Pharmaceutical Technology Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -3 Mil. Hubei Hongyuan Pharmaceutical Technology Co's Interest Coverage for the quarter that ended in Mar. 2024 was 13.74. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hubei Hongyuan Pharmaceutical Technology Co Interest Expense Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Interest Expense Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.24 -15.45 -2.38 -3.41 -13.40

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
Jun15 Dec15 Jun16 Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.83 -4.66 -3.70 -4.20 -2.56

Hubei Hongyuan Pharmaceutical Technology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Hongyuan Pharmaceutical Technology Co  (SZSE:301246) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hubei Hongyuan Pharmaceutical Technology Co's Interest Expense for the three months ended in Mar. 2024 was ¥-3 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥35 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥281 Mil.

Hubei Hongyuan Pharmaceutical Technology Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*35.137/-2.558
=13.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Interest Expense
Comparable Companies
SZSE:000756 SHSE:605507 SZSE:002020 SHSE:600195 SZSE:002581 SZSE:002219 SZSE:002332 SZSE:002099 SZSE:002424 SHSE:600216 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600
Website
http://www.hbhypharm.com
Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines